Blau Farmaceutica SA (BLAU3)

Currency in BRL
12.48
+0.12(+0.97%)
Delayed Data·
BLAU3 Scorecard
Full Analysis
Trading at a low Price / Book multiple
BLAU3 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.3012.52
52 wk Range
11.3617.61
Key Statistics
Bid/Ask
12.43 / 12.46
Prev. Close
12.36
Open
12.37
Day's Range
12.3-12.52
52 wk Range
11.36-17.61
Volume
62.3K
Average Volume (3m)
319.63K
1-Year Change
10.09%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLAU3 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.09
Upside
+28.91%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Blau Farmaceutica SA Company Profile

Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital products; biosimilars; hemoderivatives; and thrombolytics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases, special treatments, and others; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood products, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.

Employees
1900
Market
Brazil

Compare BLAU3 to Peers and Sector

Metrics to compare
BLAU3
Peers
Sector
Relationship
P/E Ratio
7.7x−4.7x−0.5x
PEG Ratio
−2.65−0.100.00
Price/Book
1.0x1.9x2.6x
Price / LTM Sales
1.2x58.3x3.3x
Upside (Analyst Target)
32.2%229.6%43.4%
Fair Value Upside
Unlock−1.4%7.1%Unlock

Analyst Ratings

5 Buy
3 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 16.09
(+28.91% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.39%
Dividend Yield
3.98%
Industry Median 2.87%
Annualised payout
0.49
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
0.36 / 0.4196
Revenue / Forecast
465.00M / 511.57M
EPS Revisions
Last 90 days

BLAU3 Income Statement

People Also Watch

19.09
BBAS3
+0.95%
31.25
PETR4
-3.93%
34.43
BBSE3
-0.09%
54.76
VALE3
+1.20%

FAQ

What Stock Exchange Does Blau Farmaceutica Trade On?

Blau Farmaceutica is listed and trades on the B3 Stock Exchange stock exchange.

What Is the Stock Symbol for Blau Farmaceutica?

The stock symbol for Blau Farmaceutica is "BLAU3."

What Is the Blau Farmaceutica Market Cap?

As of today, Blau Farmaceutica market cap is 2.20B.

What Is Blau Farmaceutica's Earnings Per Share (TTM)?

The Blau Farmaceutica EPS (TTM) is 1.39.

When Is the Next Blau Farmaceutica Earnings Date?

Blau Farmaceutica will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is BLAU3 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Blau Farmaceutica Stock Split?

Blau Farmaceutica has split 0 times.

How Many Employees Does Blau Farmaceutica Have?

Blau Farmaceutica has 1900 employees.

What is the current trading status of Blau Farmaceutica (BLAU3)?

As of 08 Aug 2025, Blau Farmaceutica (BLAU3) is trading at a price of 12.48, with a previous close of 12.36. The stock has fluctuated within a day range of 12.30 to 12.52, while its 52-week range spans from 11.36 to 17.61.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.